Management of Pneumonia in Immunocompromised Patients

Initial Assessment and Diagnosis

Immunocompromised patients with pneumonia should be treated as a healthcare-acquired infection regardless of where it was acquired, due to the high risk of multidrug-resistant pathogens, and should receive comprehensive diagnostic workup including blood cultures, urinary antigen tests, sputum cultures, and bronchoalveolar lavage (BAL) when possible 1, 2
CT scans of chest and sinuses are recommended for high-risk immunocompromised patients to assess for occult invasive fungal infections 1, 3

The Infectious Diseases Society of America recommends that immunocompromised patients with severe pneumonia should receive broad-spectrum antibiotic therapy with coverage for multidrug-resistant pathogens, including an antipseudomonal β-lactam plus either an aminoglycoside or antipseudomonal fluoroquinolone, with addition of vancomycin or linezolid if MRSA is suspected 1, 4
This triple combination provides broad coverage for Legionella species, drug-resistant gram-negative pathogens, and MRSA 1, 2, 5

The American College of Chest Physicians recommends that for documented infections, antibiotics should be continued for at least the duration of neutropenia or longer if clinically necessary, and for unexplained fever, until clear signs of marrow recovery 1
For pneumonia with identified pathogens, the duration of therapy depends on the specific organism and clinical response, typically 7-14 days 4

Regular monitoring of clinical response is essential, with adjustment of empirical regimen based on culture results and clinical progress, and consideration of additional diagnostic testing and changing antibiotics based on local resistance patterns if patients fail to improve 1, 7

Local patterns of antibiotic resistance must be considered when selecting empiric therapy, and prophylaxis for Pneumocystis pneumonia should be considered in appropriate high-risk immunocompromised patients 1, 3, 8
Avoid inadequate or limited initial regimens, as this is a major risk factor for excess mortality and prolonged hospitalization 1